Immunogenicity, Safety, Tolerability of a Plant-Made H5 VLP Influenza Vaccine

Clinical trial NCT01244867 · COMPLETED

Trial details

NCT number: NCT01244867
Sponsor: Medicago
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Virus Diseases RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections

Start date: 2010-11-01
Primary completion: 2011-07-01
Enrollment: 255

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.